CLASS II Drug recall · Reported 22 Jun 2016 · FDA Enforcement Report

Sensorcaine- MPF (Bupivacaine HCI Injection, USP) recalled

Fresenius Kabi USA is recalling Sensorcaine- MPF (Bupivacaine HCI Injection, USP), 0.75% in a Single Dose Vial, distributed nationwide in the US. The recall was initiated on 25 Apr 2016 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: 6111504, Exp 09/2019
NDC63323-461, 63323-472, 63323-463, 63323-468
UPC0363323472030, 0363323461010, 0363323463014, 0363323468026, 0363323472016, 0363323468019
Quantity recalled69225 units

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1037-2016
FDA event ID
73935
Recalling firm
Fresenius Kabi USA, Lake Zurich, IL
Manufacturer
Fresenius Kabi USA, LLC
Classification
Class II
Status
Terminated
Recall initiated
25 Apr 2016
FDA classified
16 Jun 2016
Reported
22 Jun 2016
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Particulate Matter

Timeline

25 Apr 2016Recall initiated by company
16 Jun 2016Classified by FDA+52 days
22 Jun 2016Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Presence of Particulate Matter: Glass particulate found in sterile injectable product

Product as listed by the FDA

Sensorcaine- MPF (Bupivacaine HCI Injection, USP), 0.75% in a 30 mL Single Dose Vial, Rx only, Fresenius Kabi USA LLC, Lake Zurich, IL 60047, NDC 63323-472-37

Where it was distributed

Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Presence of Particulate Matter: Glass particulate found in sterile injectable product

Which lots are affected?

Lot #: 6111504, Exp 09/2019

Where was it sold?

Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Fresenius Kabi USA

All 95

Other Bupivacaine recalls

All 54